Viking Therapeutics Takeover Target in Biotech Investing?
Investors increasingly ask whether Viking Therapeutics could become a takeover target. This article breaks down why b...
Elevate budgeting effectiveness by refining expense tracking, setting measurable goals, and reviewing progress regularly.
18,077 articlesInvestors increasingly ask whether Viking Therapeutics could become a takeover target. This article breaks down why b...
Bandwidth Inc. released a mixed Q4 2025 report that sheds light on customer growth, margins, and the path to profitab...
A stronger-than-expected May jobs report masks deeper tensions. Three warnings from analysts lay out the hidden risks...
A growing cohort of retirees is exploring a 5.5% withdrawal strategy as market conditions and Social Security plannin...
FairGambling unveils a new crypto casino review and analytics platform combining on-chain insights, provably fair ver...
Whirlpool’s scale appliance demand is a telling gauge of how households spend on big-ticket upgrades. As the housing ...
SpaceX's blockbuster IPO drew record demand and about $75 billion in funding, but tokenized pre-offers fell short for...
Snowflake's Q4 2026 results set the tone for its growth path in 2027. This analysis breaks down the numbers, the AI-d...
Imagine a beloved sneaker brand reinventing itself with AI and a bold rebrand. This speculative piece explores how su...
Cactus (WHD) finishes 2025 with solid top-line growth and steadier margins. This report breaks down cactus (whd) 2025...
Investors over 50 are recalibrating away from crowded AI bets toward dividend growth and quality stocks that pay risi...
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...